Catherine Sabatos-Peyton
- Immunology top 2%
- Oncology top 2%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Biomedical Engineering
- Co-authors
- Ana C. AndersonNandini AcharyaDavid C. WraithJohan VerhagenGlenn DranoffViviana CremascoBritta MuellerSonia Quaratino
- Topics
- Cancer Immunotherapy and Biomarkers (10 papers)Immune Cell Function and Interaction (6 papers)CAR-T cell therapy research (5 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Proceedings of the National Academy of SciencesNature CommunicationsThe Journal of Experimental Medicine
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Catherine Sabatos-Peyton
23 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Immunology 1.2k
- Oncology 1.1k
- Molecular Biology 475
- Pulmonary and Respiratory Medicine 233
- Biomedical Engineering 222
Countries citing papers authored by Catherine Sabatos-Peyton
This map shows the geographic impact of Catherine Sabatos-Peyton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Sabatos-Peyton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Sabatos-Peyton more than expected).
Fields of papers citing papers by Catherine Sabatos-Peyton
This network shows the impact of papers produced by Catherine Sabatos-Peyton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Sabatos-Peyton. The network helps show where Catherine Sabatos-Peyton may publish in the future.
Co-authorship network of co-authors of Catherine Sabatos-Peyton
This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Sabatos-Peyton. A scholar is included among the top collaborators of Catherine Sabatos-Peyton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Sabatos-Peyton. Catherine Sabatos-Peyton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 1 | |
| 3 | Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumorsbreakdown → | 257 |
| 4 | 1 | |
| 5 | 1 | |
| 6 | Tim-3 finds its place in the cancer immunotherapy landscapebreakdown → | 301 |
| 7 | 7 | |
| 8 | 3 | |
| 9 | 32 | |
| 10 | 61 | |
| 11 | 15 | |
| 12 | Prospects for combining targeted and conventional cancer therapy with immunotherapybreakdown → | 766 |
| 13 | 81 | |
| 14 | 98 | |
| 15 | 141 | |
| 16 | 41 | |
| 17 | 103 | |
| 18 | 9 | |
| 19 | 92 | |
| 20 | 124 |
About Catherine Sabatos-Peyton
Catherine Sabatos-Peyton is a scholar working on Immunology, Oncology and Genetics, having authored 23 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Immune Cell Function and Interaction (6 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (1.1k citations) and Cancer Research (137 citations). Catherine Sabatos-Peyton has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Ana C. Anderson, Nandini Acharya, David C. Wraith, Johan Verhagen, Glenn Dranoff, Viviana Cremasco, Britta Mueller, Sonia Quaratino, Adam Crystal and Philip J. Gotwals. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.